| 排名 | 分析师 | 机构 | 行业 | 年度收益率 | 6个月收益率 | 3个月收益率 | 正收益比例 | 成分股数量 | 历史最大跌幅 | 更新日期 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 唐寅灏 | 中信证券 | 医药生物 | 52.83% | 38.98% | 36.83% | 85.71% | 12 | -8.47% | 2025-06-09 |
| 2 | 彭波 | 甬兴证券 | 医药生物 | 52.83% | 48.30% | 49.45% | 40.00% | 10 | -24.57% | 2025-08-19 |
| 3 | 王道 | 申万宏源 | 医药生物 | 52.80% | 49.66% | 8.24% | 33.33% | 0 | -42.73% | 2025-11-24 |
| 4 | 王道 | 申万宏源 | 医药生物 | 52.80% | 51.23% | 6.76% | 33.33% | 0 | -42.73% | 2025-11-26 |
| 5 | 王道 | 申万宏源 | 医药生物 | 52.80% | 49.86% | 7.65% | 33.33% | 0 | -42.73% | 2025-11-27 |
| 6 | 王道 | 申万宏源 | 医药生物 | 52.80% | 52.43% | 9.21% | 33.33% | 0 | -42.73% | 2025-11-20 |
| 7 | 王道 | 申万宏源 | 医药生物 | 52.80% | 44.03% | 0.88% | 33.33% | 0 | -42.73% | 2025-12-02 |
| 8 | 王道 | 申万宏源 | 医药生物 | 52.80% | 43.28% | 0.11% | 33.33% | 0 | -42.73% | 2025-12-03 |
| 9 | 王道 | 申万宏源 | 医药生物 | 52.80% | 50.41% | 9.10% | 33.33% | 0 | -42.73% | 2025-11-21 |
| 10 | 王道 | 申万宏源 | 医药生物 | 52.80% | 39.10% | -8.36% | 33.33% | 0 | -42.73% | 2025-12-16 |
| 11 | 王道 | 申万宏源 | 医药生物 | 52.80% | 51.63% | 8.73% | 33.33% | 0 | -42.73% | 2025-11-28 |
| 12 | 王道 | 申万宏源 | 医药生物 | 52.80% | 49.66% | 3.57% | 33.33% | 0 | -42.73% | 2025-11-25 |
| 13 | 王道 | 申万宏源 | 医药生物 | 52.80% | 55.01% | 8.62% | 33.33% | 0 | -42.73% | 2025-11-19 |
| 14 | 王道 | 申万宏源 | 医药生物 | 52.80% | 54.61% | 4.82% | 33.33% | 0 | -42.73% | 2025-11-18 |
| 15 | 张林晚 | 上海证券 | 医药生物 | 52.74% | 52.88% | 29.16% | -100.00% | 1 | -18.93% | 2025-08-18 |
| 16 | 周豫 | 太平洋 | 医药生物 | 52.71% | 48.89% | 40.02% | 21.21% | 23 | -55.62% | 2025-08-19 |
| 17 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 52.70% | 52.79% | 53.48% | 12.50% | 5 | -27.10% | 2025-04-28 |
| 18 | 韩世通 | 中信证券 | 医药生物 | 52.68% | 49.07% | 40.81% | -2.04% | 6 | -63.25% | 2025-08-14 |
| 19 | 王道 | 申万宏源 | 医药生物 | 52.64% | 51.01% | 43.13% | 33.33% | 4 | -42.73% | 2025-09-03 |
| 20 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 52.60% | 57.37% | 53.32% | 12.50% | 4 | -27.10% | 2025-04-24 |